Item Type | Name |
Academic Article
|
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
|
Academic Article
|
Promotion of melanoma growth by the metabolic hormone leptin.
|
Academic Article
|
Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.
|
Academic Article
|
Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10.
|
Academic Article
|
Expression of thyrotropin-releasing hormone by human melanoma and nevi.
|
Academic Article
|
Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment.
|
Academic Article
|
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
|
Academic Article
|
The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.
|
Concept
|
Melanoma
|
Concept
|
Melanoma, Experimental
|
Academic Article
|
Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target.
|
Academic Article
|
Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2.
|
Academic Article
|
Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.
|
Academic Article
|
Tumor target binding induces phosphorylation of two M(r) 65,000 lymphokine-activated killer proteins.
|
Academic Article
|
Interaction of chemotherapy and biological response modifiers in the treatment of melanoma.
|
Academic Article
|
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma.
|
Academic Article
|
Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes.
|
Academic Article
|
Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells.
|
Academic Article
|
Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma.
|
Academic Article
|
Soluble human MDA-7/IL-24: characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes.
|
Academic Article
|
Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.
|
Academic Article
|
Clinical correlates of NRAS and BRAF mutations in primary human melanoma.
|
Academic Article
|
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma.
|
Academic Article
|
Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma.
|
Academic Article
|
Variants in melanocortin 1 receptor gene contribute to risk of melanoma--a direct sequencing analysis in a Texas population.
|
Academic Article
|
A rapid assay for stimulation of human lymphocytes by tumor-associated antigens.
|
Academic Article
|
Tumor recognition and lytic competence of IL-2-activated lymphocytes: regulation of both antibody-independent and -dependent cellular cytotoxicity via P75 IL-2 receptor.
|
Academic Article
|
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
|
Academic Article
|
Suppressive immunoregulatory factors produced by tumors.
|
Academic Article
|
Immunoregulatory factors derived from human tumors. I. Immunologic and biochemical characterization of factors that suppress lymphocyte proliferative and cytotoxic responses in vitro.
|
Academic Article
|
Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.
|
Academic Article
|
Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1.
|
Academic Article
|
Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas.
|
Academic Article
|
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.
|
Academic Article
|
Tumor iNOS predicts poor survival for stage III melanoma patients.
|
Academic Article
|
Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
|
Academic Article
|
WP760, a melanoma selective drug.
|
Academic Article
|
Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
|
Academic Article
|
Zyflamend mediates therapeutic induction of autophagy to apoptosis in melanoma cells.
|
Academic Article
|
Identification of unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma by a large-scale synthetic lethal RNAi screening.
|
Academic Article
|
Detection of tumor-associated antigen in human melanoma cell line supernatants.
|
Academic Article
|
Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein).
|
Academic Article
|
Phenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy.
|
Academic Article
|
Interleukin-1 production in tumor cells of human melanoma surgical specimens.
|
Academic Article
|
Characterization of the M(r) 65,000 lymphokine-activated killer proteins phosphorylated after tumor target binding: evidence that pp65a and pp65b are phosphorylated forms of L-plastin.
|
Academic Article
|
Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.
|
Academic Article
|
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.
|
Academic Article
|
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.
|
Academic Article
|
A novel preclinical model of human malignant melanoma utilizing bioreactor rotating-wall vessels.
|
Academic Article
|
Autoimmunity and hypothyroidism in patients with uveal melanoma.
|
Academic Article
|
Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells.
|
Academic Article
|
mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.
|
Academic Article
|
Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines.
|
Academic Article
|
Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
|
Academic Article
|
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
|
Academic Article
|
Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma.
|
Academic Article
|
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
|
Academic Article
|
Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.
|
Academic Article
|
Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.
|
Academic Article
|
Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis.
|
Academic Article
|
Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24.
|
Academic Article
|
IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.
|
Academic Article
|
The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.
|
Academic Article
|
Association of activated c-Met with NRAS-mutated human melanomas.
|
Academic Article
|
IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.
|
Academic Article
|
Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.
|
Academic Article
|
Slug expression during melanoma progression.
|
Academic Article
|
Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma.
|
Academic Article
|
Polymorphisms of nucleotide excision repair genes predict melanoma survival.
|
Academic Article
|
Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration.
|
Academic Article
|
Successful combination immunotherapy for the generation in vivo of antitumor activity with anti-CD3, interleukin 2, and tumor necrosis factor alpha.
|
Academic Article
|
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results.
|
Academic Article
|
Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.
|
Academic Article
|
Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
|
Academic Article
|
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
|
Academic Article
|
Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study.
|
Academic Article
|
NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma.
|
Academic Article
|
Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.
|
Academic Article
|
Effect of surgery on in vitro lymphocyte function.
|
Academic Article
|
Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.
|
Academic Article
|
High prevalence of hypothyroidism among patients with cutaneous melanoma.
|
Academic Article
|
Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma.
|
Academic Article
|
Expression of leptin and iNOS in oral melanomas in dogs.
|
Academic Article
|
Detection of melanoma cells in peripheral blood using reverse transcription polymerase chain reaction assay for tyrosinase mRNA.
|
Academic Article
|
Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.
|
Academic Article
|
Inflammatory IL-1?-driven JNK activation in stage III melanoma.
|
Academic Article
|
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-?.
|
Academic Article
|
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-?.
|
Academic Article
|
Dual Roles of RNF2 in Melanoma Progression.
|
Academic Article
|
Inflammatory marker testing identifies CD74 expression in melanoma tumor cells, and its expression associates with favorable survival for stage III melanoma
|
Academic Article
|
Dual roles of RNF2 in melanoma progression
|
Academic Article
|
4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma
|
Academic Article
|
Braf mutations are associated with high levels of phosphorylated RKIP in melanoma cell lines
|
Academic Article
|
Immunology comes full circle in melanoma while specific immunity is unleashed to eliminate metastatic disease, inflammatory products of innate immunity promote resistance
|
Academic Article
|
Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line
|
Academic Article
|
Elevated serum leptin levels are associated with an increased risk of sentinel lymph node metastasis in cutaneous melanoma
|
Academic Article
|
Biochemotherapy in the treatment of advanced melanoma
|
Academic Article
|
Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression
|
Academic Article
|
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ (Journal of Investigative Dermatology (2015) 135 (2901) DOI
|
Academic Article
|
Uveal melanoma
|
Academic Article
|
Hypoxia-driven mechanism of vemurafenib resistance in melanoma
|
Academic Article
|
4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis.
|
Academic Article
|
Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression.
|
Academic Article
|
Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
|
Academic Article
|
Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma.
|
Academic Article
|
Immunology Comes Full Circle in Melanoma While Specific Immunity Is Unleashed to Eliminate Metastatic Disease, Inflammatory Products of Innate Immunity Promote Resistance.
|
Academic Article
|
Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous Melanoma.
|
Academic Article
|
Uveal melanoma: From diagnosis to treatment and the science in between.
|
Academic Article
|
IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
|
Academic Article
|
Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progression.
|
Academic Article
|
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.
|
Academic Article
|
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
|
Academic Article
|
Mitochondrial dynamic alterations regulate melanoma cell progression.
|
Academic Article
|
Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma.
|
Academic Article
|
The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma.
|
Academic Article
|
Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.
|
Concept
|
Melanoma-Specific Antigens
|
Academic Article
|
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.
|
Academic Article
|
Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma.
|
Academic Article
|
The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival.
|
Academic Article
|
iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation.
|
Academic Article
|
Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.
|
Academic Article
|
Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.
|
Academic Article
|
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth.
|
Academic Article
|
Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion.
|
Academic Article
|
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.
|